TW200604139A - Preparation of pregabalin and related compounds - Google Patents
Preparation of pregabalin and related compoundsInfo
- Publication number
- TW200604139A TW200604139A TW094120286A TW94120286A TW200604139A TW 200604139 A TW200604139 A TW 200604139A TW 094120286 A TW094120286 A TW 094120286A TW 94120286 A TW94120286 A TW 94120286A TW 200604139 A TW200604139 A TW 200604139A
- Authority
- TW
- Taiwan
- Prior art keywords
- related compounds
- pregabalin
- preparation
- aminomethyl
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/12—Formation of amino and carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/04—Formation of amino groups in compounds containing carboxyl groups
- C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
- C07C227/20—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters by hydrolysis of N-acylated amino-acids or derivatives thereof, e.g. hydrolysis of carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/22—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/001—Amines; Imines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/002—Nitriles (-CN)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58167104P | 2004-06-21 | 2004-06-21 | |
US62903404P | 2004-11-18 | 2004-11-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200604139A true TW200604139A (en) | 2006-02-01 |
TWI377191B TWI377191B (en) | 2012-11-21 |
Family
ID=35295367
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094120286A TWI377191B (en) | 2004-06-21 | 2005-06-17 | Preparation of pregabalin and related compounds |
TW097126081A TWI405747B (zh) | 2004-06-21 | 2005-06-17 | 前喀巴林(pregabalin)及相關化合物之製法 |
TW097126080A TWI399361B (zh) | 2004-06-21 | 2005-06-17 | 前喀巴林(pregabalin)及相關化合物之製法 |
TW097126082A TWI357405B (en) | 2004-06-21 | 2005-06-17 | Preparation of pregabalin and related compounds |
TW097126084A TWI402248B (zh) | 2004-06-21 | 2005-06-17 | 前喀巴林(pregabalin)及相關化合物之製法 |
TW097126078A TWI396743B (zh) | 2004-06-21 | 2005-06-17 | 前喀巴林(pregabalin)及相關化合物之製法 |
Family Applications After (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW097126081A TWI405747B (zh) | 2004-06-21 | 2005-06-17 | 前喀巴林(pregabalin)及相關化合物之製法 |
TW097126080A TWI399361B (zh) | 2004-06-21 | 2005-06-17 | 前喀巴林(pregabalin)及相關化合物之製法 |
TW097126082A TWI357405B (en) | 2004-06-21 | 2005-06-17 | Preparation of pregabalin and related compounds |
TW097126084A TWI402248B (zh) | 2004-06-21 | 2005-06-17 | 前喀巴林(pregabalin)及相關化合物之製法 |
TW097126078A TWI396743B (zh) | 2004-06-21 | 2005-06-17 | 前喀巴林(pregabalin)及相關化合物之製法 |
Country Status (33)
Country | Link |
---|---|
US (4) | US20050283023A1 (zh) |
EP (1) | EP1831154B1 (zh) |
JP (5) | JP4174551B2 (zh) |
KR (3) | KR100847928B1 (zh) |
CN (2) | CN1972904B (zh) |
AP (1) | AP2466A (zh) |
AR (1) | AR049446A1 (zh) |
AT (1) | ATE455093T1 (zh) |
AU (1) | AU2005256945B2 (zh) |
BR (1) | BRPI0512347B8 (zh) |
CA (1) | CA2571040C (zh) |
CR (2) | CR8765A (zh) |
CY (1) | CY1110337T1 (zh) |
DE (1) | DE602005018965D1 (zh) |
DK (1) | DK1831154T3 (zh) |
EA (3) | EA015418B1 (zh) |
ES (1) | ES2336014T3 (zh) |
GE (1) | GEP20104895B (zh) |
HK (2) | HK1104024A1 (zh) |
HR (1) | HRP20100054T1 (zh) |
IL (1) | IL179614A0 (zh) |
MA (1) | MA28674B1 (zh) |
ME (1) | ME01067B (zh) |
MX (1) | MXPA06014228A (zh) |
NO (1) | NO338097B1 (zh) |
NZ (1) | NZ552220A (zh) |
PL (1) | PL1831154T3 (zh) |
PT (1) | PT1831154E (zh) |
RS (1) | RS51210B (zh) |
SI (1) | SI1831154T1 (zh) |
TW (6) | TWI377191B (zh) |
UA (1) | UA83575C2 (zh) |
WO (1) | WO2006000904A2 (zh) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001876A (en) | 1996-07-24 | 1999-12-14 | Warner-Lambert Company | Isobutylgaba and its derivatives for the treatment of pain |
US7417165B2 (en) | 2005-04-06 | 2008-08-26 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of pregabalin |
US7488846B2 (en) | 2005-04-11 | 2009-02-10 | Teva Pharmaceuical Industries Ltd. | Pregabalin free of lactam and a process for preparation thereof |
MX2007012606A (es) * | 2005-04-11 | 2008-01-11 | Teva Pharma | Proceso para elaborar (s)-pregabalina. |
JP2008505980A (ja) | 2005-05-10 | 2008-02-28 | テバ ファーマシューティカル インダストリーズ リミティド | イソブチルグルタル酸を有さないプレガバリン及びその調製方法 |
EP1879851B1 (en) | 2005-05-10 | 2010-11-03 | Teva Pharmaceutical Industries Ltd | Method for the preparation of pregabalin and salts thereof |
ATE523484T1 (de) * | 2005-05-10 | 2011-09-15 | Teva Pharma | Optische lösung a us 3-carbamoylmethyl-5-methyl- hexansäure |
CZ297970B6 (cs) * | 2005-08-10 | 2007-05-09 | Zentiva, A. S | Zpusob výroby (S)-3-(aminomethyl)-5-methyl-hexanové kyseliny (pregabalinu) |
ES2398579T3 (es) | 2005-09-19 | 2013-03-20 | Teva Pharmaceutical Industries Ltd | Una síntesis asimétrica de ácido (S)-(+)-3-(aminometil)-5-metilhexanoico |
EP2019817A2 (en) | 2006-05-24 | 2009-02-04 | Teva Pharmaceutical Industries Ltd. | Processes for the preparation of r-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof |
WO2007143113A2 (en) * | 2006-05-31 | 2007-12-13 | Teva Pharmaceutical Industries Ltd. | The use of enzymatic resolution for the preparation of intermediates of pregabalin |
WO2007143152A2 (en) * | 2006-05-31 | 2007-12-13 | Teva Pharmaceutical Industries Ltd. | Preparation of (s)-pregabalin-nitrile |
US8097754B2 (en) | 2007-03-22 | 2012-01-17 | Teva Pharmaceutical Industries Ltd. | Synthesis of (S)-(+)-3-(aminomethyl)-5-methyl hexanoic acid |
EP1992609A1 (en) * | 2007-05-14 | 2008-11-19 | Dipharma Francis S.r.l. | A process for the preparation of a (S)(+)-3-(aminomethyl)-5-methylhexanoic acid |
JP5157576B2 (ja) | 2007-05-14 | 2013-03-06 | 住友化学株式会社 | 光学活性2−アルキル−1,1,3−トリアルコキシカルボニルプロパンの製造方法 |
KR100846419B1 (ko) * | 2007-08-10 | 2008-07-15 | 한국과학기술원 | 프레가발린의 신규한 제조 방법 |
US20090062393A1 (en) * | 2007-08-29 | 2009-03-05 | Protia, Llc | Deuterium-enriched pregabalin |
WO2009046309A2 (en) * | 2007-10-03 | 2009-04-09 | Teva Pharmaceutical Industries Ltd. | Pregabalin -4-eliminate, pregabalin 5-eliminate, their use as reference marker and standard, and method to produce pregabalin containing low levels thereof |
ITMI20072262A1 (it) | 2007-12-03 | 2009-06-04 | Dipharma Francis Srl | Procedimento per la preparazione di acido (s)(+)-3-(amminometil)-5-metilesanoico |
US20100312010A1 (en) * | 2007-12-18 | 2010-12-09 | Watson Pharma Private Limited | Process for the Preparation of (S)-Pregabalin |
AU2008339583A1 (en) * | 2007-12-26 | 2009-07-02 | Generics [Uk] Limited | Processes to pregabalin |
SG176464A1 (en) * | 2008-05-09 | 2011-12-29 | Agency Science Tech & Res | Diagnosis and treatment of kawasaki disease |
MX2010012698A (es) | 2008-05-21 | 2011-03-15 | Sandoz Ag | Proceso para la hidrolisis enzimatica estereoselectiva del ester del acido 5-metil-3-nitro-metil-hexanoico. |
US20090312560A1 (en) * | 2008-06-10 | 2009-12-17 | Lambertus Thijs | Processes for making pregabalin and intermediates therefor |
KR20100107500A (ko) * | 2008-06-23 | 2010-10-05 | 테바 파마슈티컬 인더스트리즈 리미티드 | (s) 또는 (r)-이소-부틸-글루타릭 에스테르의 입체선택적 효소 합성방법 |
WO2010070593A2 (en) | 2008-12-19 | 2010-06-24 | Pfizer Ireland Pharmaceuticals | Malonate esters |
IT1394292B1 (it) | 2009-05-07 | 2012-06-06 | Dipharma Francis Srl | Procedimento per la sintesi di pregabalina |
WO2011141923A2 (en) | 2010-05-14 | 2011-11-17 | Lupin Limited | Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin |
WO2012025861A1 (en) | 2010-08-23 | 2012-03-01 | Pfizer Manufacturing Ireland | Process for the preparation of ( s ) - 3 - cyano - 5 - methylhexanoic acid derivatives adn of pregabalin |
WO2012059797A1 (en) * | 2010-11-04 | 2012-05-10 | Lupin Limited | Process for synthesis of (s) - pregabalin |
KR101306585B1 (ko) * | 2011-04-14 | 2013-09-10 | 한국외국어대학교 연구산학협력단 | 프레가발린의 제조방법 |
CN102952057B (zh) * | 2012-11-07 | 2015-09-09 | 浙江普洛家园药业有限公司 | 一种4-异丁基吡咯烷-2-酮的制备方法 |
JP6225490B2 (ja) * | 2013-05-31 | 2017-11-08 | 大日本印刷株式会社 | 医薬品包装体 |
US10076550B2 (en) * | 2014-06-25 | 2018-09-18 | Council Of Scientific & Industrial Research | Synergistic pharmaceutical composition for gastroinestinal disorders |
WO2016075082A1 (en) | 2014-11-10 | 2016-05-19 | Sandoz Ag | Stereoselective reductive amination of alpha-chiral aldehydes using omega-transaminases for the synthesis of precursors of pregabalin and brivaracetam |
CN104557576B (zh) * | 2014-12-19 | 2019-07-19 | 浙江华海药业股份有限公司 | 一种高纯度普瑞巴林的制备方法 |
CN105348125A (zh) * | 2015-11-26 | 2016-02-24 | 太仓运通生物化工有限公司 | 一种以异戊醛为原料合成普瑞巴林的方法 |
CN107445864B (zh) * | 2017-08-09 | 2020-01-17 | 无锡殷达尼龙有限公司 | 一种纯化长碳链氰基酸产物的方法 |
CN108358799B (zh) * | 2018-04-24 | 2020-11-10 | 贵州师范大学 | 一种普瑞巴林的制备方法 |
CN109503403B (zh) * | 2018-12-21 | 2021-11-16 | 卓和药业集团股份有限公司 | 一种普瑞巴林的拆分方法 |
CN113248416B (zh) * | 2020-02-10 | 2024-03-26 | 江西博腾药业有限公司 | 1-((苄氧基)羰基)-4-乙基吡咯烷-3-羧酸的制备方法及其应用 |
EP4103168A4 (en) | 2020-02-14 | 2024-04-24 | Council Scient Ind Res | PROCESS FOR THE PRODUCTION OF GAMMA-AMINOBUTRY ACIDS AND THEIR ANALOGUES |
CN111205288B (zh) | 2020-02-19 | 2021-03-30 | 四川大学 | 一种(1S,12bS)内酰胺酯化合物的合成方法 |
CN113651717A (zh) * | 2021-08-05 | 2021-11-16 | 浙江工业大学 | 一种光学纯异丁基丁二腈的消旋方法 |
CN113880724A (zh) * | 2021-12-06 | 2022-01-04 | 南京桦冠生物技术有限公司 | 一种3-(2-氨基苯基)-2-丙烯酸酯的制备方法 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3125583A (en) * | 1964-03-17 | Hjnc oxchaxohxchc o oh | ||
US637767A (en) * | 1899-09-25 | 1899-11-28 | Gaylard W Denyes | Grain-drill. |
SU452196A1 (ru) * | 1973-02-12 | 2001-09-20 | Филиал Всесоюзного Научно-Исследовательского Химико-Фармацевтического Института Им. Серго Орджоникидзе | СПОСОБ ПОЛУЧЕНИЯ γ-АМИНОМАСЛЯНОЙ КИСЛОТЫ |
JPS60338B2 (ja) * | 1980-12-16 | 1985-01-07 | 日本新薬株式会社 | 酪酸誘導体の製法 |
US4428887A (en) * | 1982-07-14 | 1984-01-31 | Monsanto Company | Method of producing mono-substituted terminal diesters |
US5618710A (en) * | 1990-08-03 | 1997-04-08 | Vertex Pharmaceuticals, Inc. | Crosslinked enzyme crystals |
US6197819B1 (en) * | 1990-11-27 | 2001-03-06 | Northwestern University | Gamma amino butyric acid analogs and optical isomers |
US5616793A (en) * | 1995-06-02 | 1997-04-01 | Warner-Lambert Company | Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid |
US5637767A (en) * | 1995-06-07 | 1997-06-10 | Warner-Lambert Company | Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid |
DE19623142A1 (de) * | 1996-06-10 | 1997-12-11 | Huels Chemische Werke Ag | Enantiomerenangereicherte, durch einen tertiären Kohlenwasserstoffrest substituierte Malonsäuremonoester sowie deren Herstellung |
US6001876A (en) * | 1996-07-24 | 1999-12-14 | Warner-Lambert Company | Isobutylgaba and its derivatives for the treatment of pain |
JPH10245369A (ja) * | 1997-03-03 | 1998-09-14 | Ajinomoto Co Inc | セリン誘導体の製造方法 |
US6329429B1 (en) * | 1997-06-25 | 2001-12-11 | Warner-Lambert Company | Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases |
AU9019198A (en) * | 1997-08-19 | 1999-03-08 | Warner-Lambert Company | Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants |
AU8668598A (en) * | 1997-08-20 | 1999-03-08 | University Of Oklahoma, The | Gaba analogs to prevent and treat gastrointestinal damage |
US6127418A (en) * | 1997-08-20 | 2000-10-03 | Warner-Lambert Company | GABA analogs to prevent and treat gastrointestinal damage |
RU2143002C1 (ru) * | 1997-12-24 | 1999-12-20 | Акционерное общество открытого типа "Мосагроген" | СПОСОБ ПОЛУЧЕНИЯ γ-АМИНОМАСЛЯНОЙ КИСЛОТЫ |
WO2000002546A2 (en) * | 1998-07-09 | 2000-01-20 | Warner-Lambert Company | Use of caba-analogues for treating insomnia |
JP2002520286A (ja) * | 1998-07-09 | 2002-07-09 | ワーナー−ランバート・カンパニー | Gaba類縁体及びカフェインを含んでなる組成物 |
EP1121114B1 (en) * | 1998-10-16 | 2007-01-10 | Warner-Lambert Company Llc | Use of gaba analogs for the manufacture of a medicament for the treatment of mania and bipolar disorders |
EA004934B1 (ru) * | 2000-01-27 | 2004-10-28 | Уорнер-Ламберт Компани | Асимметрический синтез прегабалина |
GB0004297D0 (en) * | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
US6931007B2 (en) * | 2001-07-25 | 2005-08-16 | Longboard, Inc. | System and method of serving data messages |
EP1333087A1 (en) * | 2002-02-05 | 2003-08-06 | Avantium International B.V. | Crosslinked enzyme aggregates and crosslinking agent therefore |
US20030225149A1 (en) * | 2002-04-30 | 2003-12-04 | Blazecka Peter G. | Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids |
FR2849024B1 (fr) * | 2002-12-20 | 2007-11-02 | Aventis Pharma Sa | Nouveaux composes chiraux derives d'esters de l'acide hexanoique, procede et intermediaires de preparation, utilisation a la synthese de l'acide 2-(bromomethyl)2-ethyl hexanoique chiral |
JP2006061112A (ja) * | 2004-08-30 | 2006-03-09 | Sumitomo Chemical Co Ltd | 光学活性な2−(シクロペンチルメチル)−マロン酸モノエステルの製造方法 |
WO2007143113A2 (en) * | 2006-05-31 | 2007-12-13 | Teva Pharmaceutical Industries Ltd. | The use of enzymatic resolution for the preparation of intermediates of pregabalin |
-
2005
- 2005-06-09 EA EA200800908A patent/EA015418B1/ru not_active IP Right Cessation
- 2005-06-09 EP EP05753107A patent/EP1831154B1/en active Active
- 2005-06-09 ES ES05753107T patent/ES2336014T3/es active Active
- 2005-06-09 AU AU2005256945A patent/AU2005256945B2/en not_active Ceased
- 2005-06-09 KR KR1020087003008A patent/KR100847928B1/ko active IP Right Grant
- 2005-06-09 PT PT05753107T patent/PT1831154E/pt unknown
- 2005-06-09 JP JP2007517522A patent/JP4174551B2/ja active Active
- 2005-06-09 EA EA200800909A patent/EA200800909A1/ru unknown
- 2005-06-09 CA CA002571040A patent/CA2571040C/en not_active Expired - Fee Related
- 2005-06-09 DK DK05753107.1T patent/DK1831154T3/da active
- 2005-06-09 CN CN2005800204949A patent/CN1972904B/zh active Active
- 2005-06-09 RS RSP-2010/0113A patent/RS51210B/sr unknown
- 2005-06-09 AT AT05753107T patent/ATE455093T1/de active
- 2005-06-09 BR BRPI0512347A patent/BRPI0512347B8/pt not_active IP Right Cessation
- 2005-06-09 ME MEP-2010-50A patent/ME01067B/me unknown
- 2005-06-09 PL PL05753107T patent/PL1831154T3/pl unknown
- 2005-06-09 MX MXPA06014228A patent/MXPA06014228A/es active IP Right Grant
- 2005-06-09 KR KR1020087003014A patent/KR100847929B1/ko active IP Right Grant
- 2005-06-09 GE GEAP20059756A patent/GEP20104895B/en unknown
- 2005-06-09 NZ NZ552220A patent/NZ552220A/en unknown
- 2005-06-09 CN CN2010105812765A patent/CN102102114B/zh active Active
- 2005-06-09 WO PCT/IB2005/001924 patent/WO2006000904A2/en active Application Filing
- 2005-06-09 DE DE602005018965T patent/DE602005018965D1/de active Active
- 2005-06-09 KR KR1020087003010A patent/KR100847927B1/ko active IP Right Grant
- 2005-06-09 EA EA200602099A patent/EA011765B1/ru not_active IP Right Cessation
- 2005-06-09 SI SI200530907T patent/SI1831154T1/sl unknown
- 2005-06-09 AP AP2006003846A patent/AP2466A/xx active
- 2005-06-17 TW TW094120286A patent/TWI377191B/zh active
- 2005-06-17 AR ARP050102504A patent/AR049446A1/es active IP Right Grant
- 2005-06-17 TW TW097126081A patent/TWI405747B/zh active
- 2005-06-17 TW TW097126080A patent/TWI399361B/zh active
- 2005-06-17 TW TW097126082A patent/TWI357405B/zh active
- 2005-06-17 TW TW097126084A patent/TWI402248B/zh active
- 2005-06-17 TW TW097126078A patent/TWI396743B/zh active
- 2005-06-21 US US11/157,585 patent/US20050283023A1/en not_active Abandoned
- 2005-09-06 UA UAA200612380A patent/UA83575C2/uk unknown
-
2006
- 2006-11-20 NO NO20065329A patent/NO338097B1/no not_active IP Right Cessation
- 2006-11-23 CR CR8765A patent/CR8765A/es unknown
- 2006-11-27 IL IL179614A patent/IL179614A0/en active IP Right Grant
- 2006-12-21 MA MA29548A patent/MA28674B1/fr unknown
-
2007
- 2007-07-27 HK HK07108223.5A patent/HK1104024A1/xx unknown
- 2007-12-27 JP JP2007335543A patent/JP4782101B2/ja active Active
- 2007-12-27 JP JP2007335498A patent/JP4777332B2/ja active Active
- 2007-12-27 JP JP2007335532A patent/JP4966183B2/ja active Active
-
2008
- 2008-05-29 JP JP2008141241A patent/JP4800346B2/ja active Active
- 2008-10-20 US US12/254,336 patent/US7838686B2/en active Active
-
2010
- 2010-01-29 HR HR20100054T patent/HRP20100054T1/hr unknown
- 2010-03-22 CY CY20101100272T patent/CY1110337T1/el unknown
- 2010-11-22 US US12/951,429 patent/US8044227B2/en active Active
-
2011
- 2011-09-12 CR CR20110483A patent/CR20110483A/es unknown
- 2011-09-28 US US13/247,032 patent/US8134023B2/en active Active
- 2011-12-20 HK HK11113743.0A patent/HK1161307A1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200604139A (en) | Preparation of pregabalin and related compounds | |
WO2005123099A3 (en) | Methods and compositions for accelerating alcohol metabolism | |
IL185031A0 (en) | Method for the preparation of pregabalin and salts thereof | |
SI1745136T1 (sl) | Postopek za encimsko pripravo (S)-3-ciano-5-metilheksanojske kisline | |
SG152239A1 (en) | Compounds for proteasome enzyme inhibition | |
TW200628159A (en) | IL-12 modulatory compounds | |
TW200621776A (en) | Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines | |
TW200613257A (en) | Novel method for the preparation of intermediates useful for the synthesis of vitamin d analogues | |
TW200730518A (en) | Crystalline forms of docetaxel and processes for their preparation | |
TW200720232A (en) | Crystalline solid forms of tigecycline and methods of preparing same | |
WO2006069719A3 (en) | Lyophilization of virosomes | |
EP1576117A3 (en) | Method of obtaining viable human liver cells, including hepatic stem/progenitor cells | |
UA92894C2 (ru) | Способ приготовления и применения композиции адсорбента фосфата, адсорбент фосфата, композиция адсорбента фосфата | |
AP2492A (en) | Novel compositions of fungal inocula, method for the preparation thereof and use thereof for improving the growth of cultures | |
SG135196A1 (en) | Process for the preparation of enantiomerically pure 1-substituted-3- aminoalcohols | |
TW200613308A (en) | Cyclobutanetetracarboxylate compound and preparation method thereof | |
WO2008072976A3 (en) | Synthesis of a radiofluorinated peptide using microwave activation technology | |
EP1795586A4 (en) | PROCESS FOR MUSHROOM CULTIVATION | |
MX2009003755A (es) | Cristal novedoso de (s)-(+)-2-(2-clorofenil)-2-hidroxietil carbamato. | |
AU2003230767A1 (en) | Methods of promoting cell viability | |
EP2147916A4 (en) | PROCESS FOR THE PREPARATION OF SYNTHETIC TAXANES | |
TW200420530A (en) | Novel method for preparing methyl 2-diphenylmethylsulfinylacetate | |
WO2006062901A3 (en) | Silacycle compounds and methods of use thereof | |
MY159745A (en) | Method of preparing deoxyribofuranose compounds | |
GB2447584A (en) | Sonication methods for screening and preparing solid forms |